Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis

BACKGROUND: The clinical efficacy of rupatadine in terms of responders has not been previously explored in perennial allergic rhinitis (PAR). METHODS: This pooled analysis included data from 6 randomised, double-blind, placebo-controlled trials conducted in PAR patients treated with rupatadine 10 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Valero, Antonio, Izquierdo, Iñaki, Kowalski, Marek L., Scadding, Glenis K., Bousquet, Jean, Mullol, Joaquim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181536/
https://www.ncbi.nlm.nih.gov/pubmed/32346387
http://dx.doi.org/10.1186/s13223-020-00425-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181536/
https://www.ncbi.nlm.nih.gov/pubmed/32346387
http://dx.doi.org/10.1186/s13223-020-00425-1

Ejemplares similares